Home | Welcome to Contract Pharma   
Last Updated Sunday, May 26 2013
Print RSS Feed

Breaking News

Related Searches: Promotions & Moves

June 10, 2008
Daniel G. Franklin has been appointed regional manager, compliance services, Integrated Project Services (IPS), based in Indiana. Also, Matthew Stefanowicz has been appointed regional manager, compliance services based in North Carolina.   …  Read More »

June 10, 2008
Cold Chain Technologies (CCT) has opened its new plant in Reno, NV and has expanded its plants in Massachusetts and Tennessee, doubling its Massachusetts thermal testing facility. Also, CCT has named Jeff Bernardi, Reno plant manager and Jamie Chaste…  Read More »

June 9, 2008
Anna S. Richo has been appointed senior vice president, Worldwide Compliance, Amgen. Ms. Richo will head the organization responsible for the company’s corporate compliance and business ethics programs. She will report to Amgen chairman and chi…  Read More »

June 9, 2008
Takeda Global R&D Center reported results from five Phase III studies of alogliptin as an oral treatment for type 2 diabetes, which has been shown to be a highly selective inhibitor of dipeptidyl peptidase-4 (DPP-4). Alogliptin administered once…  Read More »

June 9, 2008
Amylin Pharmaceuticals, Lilly and Alkermes announced results from a 30-week study comparing the efficacy of exenatide once weekly (a long-acting release formulation of exenatide) to Byetta (the injectable version of exenatide), in type 2 diabetes. Pa…  Read More »

June 6, 2008
Patheon 2Q Revenues: $186 million (16%) 2Q Loss: $8.5 million (loss of $22 million in 2Q07) YTD Revenues: $350 million (+14%) YTD Loss: $23.7 million (loss of $24 million YTD07) Comments: Commercial manufacturing revenues in the quarte…  Read More »

June 6, 2008
GlaxoSmithKline has completed its acquisition of Sirtris Pharmaceuticals, Inc. for approximately $720 million in cash. Through the acquisition GSK has enhanced its metabolic, neurology, immunology and inflammation research efforts by establishing a p…  Read More »

June 6, 2008
Charles E. Triano has been named senior vice president, investor relations, Pfizer, effective June 23. Mr. Triano will be responsible for all investor relations functions, including communicating the financial and operational performance of the compa…  Read More »

June 5, 2008
Ipsen, S.A. and Tercica have entered into a definitive merger agreement under which an affiliate of Ipsen will acquire all outstanding shares (approximately 43%) of Tercica for approximately $663 million in cash. This transaction, which is subject to…  Read More »

June 5, 2008
Merck Serono and development partner ZymoGenetics have initiated a Phase II/III trial of atacicept in patients with systemic lupus erythematosus (SLE) to evaluate the efficacy and safety of the drug for the treatment of SLE. The study is being con…  Read More »

June 5, 2008
Michael Faughnan has been named business development director of Eden Biodesign's U.S. subsidiary, Eden Biodesign, Inc. He will support Dr. Roger Lias, president of Eden Biodesign, Inc. and group commercial director, with the company’s expansio…  Read More »

June 4, 2008
Novartis plans to acquire Protez Pharmaceuticals for as much as $400 million. Protez is a privately held biotechnology company based in Malvern, PA. Its lead drug candidate, PZ-601, is an injectable antibiotic in Phase II development for the potentia…  Read More »

June 4, 2008
Microtest Laboratories has doubled its microbial identification and analytical services with the purchase of an additional MicroSeq Microbial Identification System. The MicroSeq is a DNA sequence-based system used to identify bacteria isolates that a…  Read More »

June 4, 2008
Kathleen Hodges has been appointed to the new position of vice president of quality, BASi (Bioanalytical Systems, Inc.). Ms. Hodges has corporate-wide responsibility for all matters relating to quality and regulatory issues. She has a background in q…  Read More »

June 3, 2008
Patheon, Inc. has established a Japanese subsidiary based in Tokyo, Japan. Patheon K.K. will operate from a new office located in the Nihonbashi district of central Tokyo and will support Patheon's business requirements in the region. Local staff wil…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On